Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,109,747
  • Shares Outstanding, K 73,991
  • Annual Sales, $ 1,717 M
  • Annual Income, $ 206,900 K
  • 60-Month Beta 1.25
  • Price/Sales 6.41
  • Price/Cash Flow 34.84
  • Price/Book 7.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.72
  • Number of Estimates 4
  • High Estimate 0.73
  • Low Estimate 0.70
  • Prior Year 0.73
  • Growth Rate Est. (year over year) -1.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
136.78 +9.03%
on 10/24/19
151.15 -1.34%
on 11/18/19
+8.28 (+5.88%)
since 10/18/19
3-Month
136.73 +9.07%
on 10/02/19
152.10 -1.95%
on 09/06/19
+4.07 (+2.81%)
since 08/16/19
52-Week
91.75 +62.54%
on 12/24/18
152.10 -1.95%
on 09/06/19
+38.99 (+35.40%)
since 11/16/18

Most Recent Stories

More News
West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West's Ready Pack(TM) System

(Booths #F62 & #F10 -Hall 11.1) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and the international technology group SCHOTT,...

WST : 149.13 (-0.68%)
XRAY or WST: Which Is the Better Value Stock Right Now?

XRAY vs. WST: Which Stock Is the Better Value Option?

XRAY : 56.27 (-0.64%)
WST : 149.13 (-0.68%)
West Launches Two New Elastomer Product Innovations at CPhI Worldwide

(Booth #111F62)--West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced two innovative product offerings in the elastomer...

WST : 149.13 (-0.68%)
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 11.27% and 0.81%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

WST : 149.13 (-0.68%)
West Pharmaceutical: 3Q Earnings Snapshot

EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported third-quarter earnings of $56.3 million.

WST : 149.13 (-0.68%)
West Announces Third-Quarter 2019 Results

West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.

WST : 149.13 (-0.68%)
West Introduces NovaPure® 3mL Cartridge Components and Features SmartDose® Gen. II 10mL Drug Delivery System at PDA Universe of Pre-filled Syringes and Injection Devices

(Booths #F44 & #F51)--West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced two innovative product offerings at the...

WST : 149.13 (-0.68%)
West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake...

WST : 149.13 (-0.68%)
West to Host Third-Quarter 2019 Conference Call

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before...

WST : 149.13 (-0.68%)
Top 5 Companies in the Health Care Supplies Industry with the Best Relative Performance (ALGN , WST , COO , XRAY , MMSI )

Here are the top 5 stocks in the Health Care Supplies industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ALGN : 268.51 (+1.74%)
COO : 305.69 (+1.23%)
WST : 149.13 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade WST with:

Business Summary

West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines...

See More

Key Turning Points

2nd Resistance Point 152.05
1st Resistance Point 150.59
Last Price 149.13
1st Support Level 148.23
2nd Support Level 147.33

See More

52-Week High 152.10
Last Price 149.13
Fibonacci 61.8% 129.05
Fibonacci 50% 121.93
Fibonacci 38.2% 114.80
52-Week Low 91.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar